课题基金 / 基金详情

OB GENE IN HUMAN OBESITY

OB GENE IN HUMAN OBESITY
人类肥胖中的 OB 基因
批准号:
2882805
负责人:
DAVID E COMINGS
金额:
$7.33万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-03-06 至 2000-02-29

项目摘要

项目成果

DAVID E COMINGS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Taken from the applicant's Abstract) Obesity research was elevated to a new level by the recent discovery of the hormone leptin, a protein that appears to mediate both appetite and energy expenditure, and by the identification of the human OB gene, which encodes leptin. In prior studies at our laboratory we have examined three OB gene microsatellite polymorphisms (D7S514, D7S635 and D7S1875) in samples of obese and non-obese human subjects. We found that these markers were significantly associated with waist and hip measurements, body mass index (BMI), percent body fat, and two specific eating behaviors: eating when under stress, and eating when bored. However, the most robust associations were with anxiety and depression. Consistent with the literature, the anxiety/depression findings were mirrored by a genetic association with thyroid stimulating hormone (TSH), suggesting that this gene mediates eating behavior and energy via classical hypothalamic-pituitary-adrenocortical (HPA) pathways that influence psychological substrates. The proposed study will attempt to replicate and extend these findings by examining these polymorphisms in 400 new cases of obese and non-obese subjects, 200 of whom are undergoing fenfluramine/phenteramine treatment for obesity. Blood samples and assessments will be obtained both at entry to the study and at 6-month follow-up, in order to determine whether these markers are associated with treatment outcome and with changes in levels of leptin, stress, hormones and TSH.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
OB GENE IN HUMAN OBESITY
VULNERABILITY TO DRUG ABUSE--PREVALENCE OF DA RECEPTORS
VULNERABILITY TO DRUG ABUSE--PREVALENCE OF DA RECEPTORS
VULNERABILITY TO DRUG ABUSE--PREVALENCE OF DA RECEPTORS
海外基金